Commonwealth Equity Services LLC decreased its stake in Chemed Co. (NYSE:CHE - Free Report) by 92.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 659 shares of the company's stock after selling 8,520 shares during the quarter. Commonwealth Equity Services LLC's holdings in Chemed were worth $349,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of CHE. UMB Bank n.a. grew its holdings in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares during the period. Trust Co. of Vermont acquired a new position in Chemed in the fourth quarter valued at about $34,000. Tortoise Investment Management LLC increased its holdings in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after acquiring an additional 34 shares in the last quarter. SRS Capital Advisors Inc. raised its position in shares of Chemed by 39.2% during the fourth quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock worth $72,000 after purchasing an additional 38 shares during the period. Finally, Allworth Financial LP lifted its holdings in shares of Chemed by 2,057.1% during the 4th quarter. Allworth Financial LP now owns 151 shares of the company's stock valued at $83,000 after purchasing an additional 144 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.
Read Our Latest Research Report on CHE
Chemed Price Performance
Shares of CHE traded up $1.05 during midday trading on Friday, hitting $591.44. The stock had a trading volume of 104,450 shares, compared to its average volume of 97,198. The firm has a market cap of $8.64 billion, a price-to-earnings ratio of 29.89, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. The company has a 50 day simple moving average of $583.16 and a two-hundred day simple moving average of $567.95. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $625.09.
Chemed Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is 10.05%.
Insiders Place Their Bets
In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.32% of the company's stock.
Chemed Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.